Dr. Troy Holdeman, MD
Claim this profileGSK Investigational Site
Studies Respiratory Syncytial Virus Infection
Studies Respiratory Syncytial Virus
5 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Troy Holdeman, MD is currently running
RSV Vaccine
for Respiratory Syncytial Virus
This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) and children (18-59 months of age) who may or may not have had prior respiratory syncytial virus (RSV) infection.
Recruiting0 awards Phase 1 & 2
RSV Vaccine
for Adults 60+
The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 consecutive RSV seasons (approximately 60 months) of a single dose of RSVPreF3 OA vaccine, * To give the opportunity to participants who received only placebo in the RSVOA=ADJ- 006 study, to receive a dose of the RSVPreF3 OA vaccine and collect additional safety information.
Recruiting2 awards Phase 31 criteria
More about Troy Holdeman, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Troy Holdeman, MD has experience with
- RSVPreF3 OA Vaccine
- Pentosan Polysulfate Sodium
- Placebo (Sodium Chloride Injection, 0.9%)
- BLB-201
- GSK4382276A
Breakdown of trials Troy Holdeman, MD has run
Respiratory Syncytial Virus Infection
Respiratory Syncytial Virus
Osteoarthritis Treatment Costs
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Troy Holdeman, MD specialize in?
Troy Holdeman, MD focuses on Respiratory Syncytial Virus Infection and Respiratory Syncytial Virus. In particular, much of their work with Respiratory Syncytial Virus Infection has involved treating patients, or patients who are undergoing treatment.
Is Troy Holdeman, MD currently recruiting for clinical trials?
Yes, Troy Holdeman, MD is currently recruiting for 2 clinical trials in Newton Kansas. If you're interested in participating, you should apply.
Are there any treatments that Troy Holdeman, MD has studied deeply?
Yes, Troy Holdeman, MD has studied treatments such as RSVPreF3 OA vaccine, Pentosan Polysulfate Sodium, Placebo (Sodium Chloride Injection, 0.9%).
What is the best way to schedule an appointment with Troy Holdeman, MD?
Apply for one of the trials that Troy Holdeman, MD is conducting.
What is the office address of Troy Holdeman, MD?
The office of Troy Holdeman, MD is located at: GSK Investigational Site, Newton, Kansas 67114 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.